HNRNPA1L3: A Potential Drug Target and Biomarker (G642659)

Target Name: HNRNPA1L3

NCBI ID: G642659

Other Name(s): heterogeneous nuclear ribonucleoprotein A1 pseudogene 48 | HNRNPA1P48 | heterogeneous nuclear ribonucleoprotein A1 like 3 | Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48

HNRNPA1L3: A Potential Drug Target and Biomarker

Heterogeneous nuclear ribonucleoprotein (HNRNPA1L3) is a protein that is expressed in various tissues and organs, including brain, heart, liver, and muscle. It is a key component of the nuclear ribonucleoprotein complex, which is responsible for regulating gene expression in the cell. HNRNPA1L3 has been identified as a potential drug target and biomarker due to its unique expression pattern and its involvement in various cellular processes.

HNRNPA1L3 is a 22-kDa protein that consists of 156 amino acids. It is a single exon gene that is expressed in various tissues and organs. HNRNPA1L3 is highly expressed in the brain, where it is found in the prefrontal cortical cortical layer, as well as in the heart, liver, and muscle. It is also expressed in the placenta, which supports the development and maintenance of fetal tissues.

One of the key functions of HNRNPA1L3 is its role in regulating gene expression. It is a key component of the nuclear ribonucleoprotein complex, which is responsible for binding to specific gene loci and regulating the expression of gene products. This complex plays a crucial role in ensuring that the cell has an accurate copy of the genetic information and that the information is properly transcribed into RNA.

HNRNPA1L3 is also involved in various cellular processes that are essential for the survival and function of the cell. For example, it is involved in the regulation of cell adhesion, which is critical for the maintenance of tissue structure and the development of various diseases. It is also involved in the regulation of cell cycle progression, which is critical for the growth and development of the cell.

In addition to its role in regulating gene expression and cellular processes, HNRNPA1L3 is also a potential drug target. Its unique expression pattern and its involvement in various cellular processes make it an attractive target for small molecule inhibitors. HNRNPA1L3 has been shown to play a role in the regulation of cellular processes that are important for the development and survival of cancer cells.

One of the most promising compounds that have been identified as potential inhibitors of HNRNPA1L3 is curcumin, which is an alkaloid that is derived from the curcuma plant. Curcumin has been shown to have various biological activities, including anti-inflammatory, antioxidant, and anti-tumor effects.

In addition to its potential anti-inflammatory and anti-tumor effects, curcumin has also been shown to have its effects on the regulation of gene expression. It has been shown to inhibit the expression of genes involved in cell adhesion, cell cycle progression, and the regulation of cell survival.

Curcumin is commonly used in various forms, including oil, seeds, and dried herbs. It is available as a dietary supplement and has been shown to have various health benefits, including anti-inflammatory effects, antioxidant effects, and anti-tumor effects.

In conclusion, HNRNPA1L3 is a protein that is involved in various cellular processes that are essential for the survival and function of the cell. Its unique expression pattern and its involvement in the regulation of gene expression make it an attractive target for small molecule inhibitors, such as curcumin. Further research is needed to fully understand the role of HNRNPA1L3 in various cellular processes and its potential as a drug target and biomarker.

Protein Name: Heterogeneous Nuclear Ribonucleoprotein A1 Like 3

More Common Targets